Epilepsy is a frequent child pathology, 40% of all epileptic people are younger than 15 years
of age. Specific problems such as selecting the appropriate antiepileptic drug can be faced …

Studies designed specifically for the pediatric population are needed to assess the
tolerability and safety of the new antiepileptic drugs. The purpose of this study was to …

Background Few clinical studies have assessed the efficacy and safety of oxcarbazepine
(OXC) oral suspension in Asian pediatric patients and particularly in infants. The aim of this …

Following a previous preliminary report on a group of children suffering from partial
epilepsies, we present the final considerations on the same group in order to evaluate the …

PURPOSE: To evaluate the long-term efficacy, tolerability, and safety of oxcarbazepine
(OXC) in children with epilepsy. METHODS: We enrolled 36 patients (median age 7.75) with …

PURPOSE: We conducted a prospective, multicenter, open label trial to evaluate the
effectiveness of oxcarbazepine (OXC) oral suspension as monotherapy for children newly …

Relatively few well-designed studies have demonstrated the long-term safety and tolerability
of newer antiepileptic drugs (AEDs) in a large group of children. Extensive clinical data from …

Oxcarbazepine (OCBZ) is one of the new antiepileptic drugs (AEDs) currently available in
several countries. While it is rated as having fewer side effects than carbamazepine (CBZ) …

Recent trials and extensive postmarketing use confirm the efficacy and safety of
oxcarbazepine (OXC) as a first-line treatment for adults and children with simple partial …

Almost 50 million people in the world, a third of whom children, suffer from epilepsy. Up to
30% of them develop refractory epilepsy. In this group, there is a need for more efficacious …